Advertisement
Singapore markets open in 2 hours 23 minutes

  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • Dow

    38,503.69
    +263.71 (+0.69%)
     

  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     

  • Bitcoin USD

    66,395.74
    -395.48 (-0.59%)
     

  • CMC Crypto 200

    1,430.27
    +15.51 (+1.10%)
     

  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     

  • Gold

    2,336.00
    -6.10 (-0.26%)
     

  • Crude Oil

    83.37
    +0.01 (+0.01%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     

  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     

  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     

  • Jakarta Composite Index

    7,110.81
    -7,073.82 (-49.87%)
     

  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Company News for Mar 3, 2020

Zacks Equity Research
·1-min read

  • Shares of Forty Seven, Inc. FTSV jumped 61.9% after the Gilead Sciences said it plans to buy the cancer therapy company

  • Shares of Mobile Mini, Inc. MINI soared 5.2% after WillScot Corp. announced plans to acquire the company in a deal worth about $1.9 billion

  • Shares of Karyopharm Therapeutics Inc. KPTI leaped 69.7% after the company announced that its Phase 3 BOSTON study met its primary endpoint with significant increase in progression-free survival in patients with multiple myeloma

  • Shares of Alphatec Holdings, Inc. ATEC rose 9.4% after the company announced plans to acquire EOS imaging in a cash and stock deal valued at up to $121.9 million


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Mobile Mini, Inc. (MINI) : Free Stock Analysis Report
 
Karyopharm Therapeutics Inc. (KPTI) : Free Stock Analysis Report
 
Alphatec Holdings, Inc. (ATEC) : Free Stock Analysis Report
 
Forty Seven, Inc. (FTSV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.